Jun Dang, Yutang Yao, Yingchun Li, Xiaofei Tan, Zhenyan Ye, Yi Zhao, Shiwei Qing, Ying Kou, Xiao Jiang, Hao Lu, Shirong Chen, Meng Zhao, Zhuzhong Cheng
18 F-PSMA-1007 PET/CT imaging is increasingly used for the diagnosis, staging, and efficacy assessment of patients with prostate cancer. Compared with other PSMA tracers, 18 F-PSMA-1007 is mainly cleared by the liver and bile and has lower urinary clearance, thus allowing a better assessment of the lesions around the bladder. However, there were some patients who showed an obvious concentration of the 18 F-PSMA-1007 in the bladder, which may affect the observation of peripheral lesions, but the mechanism of this change is unknown...
2023: Frontiers in Medicine